The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(2-([1,1'-Biphenyl]-4-yl)-4-methylthiazol-5-yl)-pyrimidin-2-yl)-4-methylpiperazine-1-carboximidamide ID: ALA4210722
PubChem CID: 145966650
Max Phase: Preclinical
Molecular Formula: C26H27N7S
Molecular Weight: 469.62
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc(-c2ccc(-c3ccccc3)cc2)sc1-c1ccnc(NC(=N)N2CCN(C)CC2)n1
Standard InChI: InChI=1S/C26H27N7S/c1-18-23(22-12-13-28-26(30-22)31-25(27)33-16-14-32(2)15-17-33)34-24(29-18)21-10-8-20(9-11-21)19-6-4-3-5-7-19/h3-13H,14-17H2,1-2H3,(H2,27,28,30,31)
Standard InChI Key: XHYLEDJYOQJNIS-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
15.7041 -4.4810 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8835 -4.3964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5464 -3.6434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0300 -2.9750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8507 -3.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1877 -3.8126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0412 -5.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8618 -5.3186 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5576 -5.9024 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6930 -2.2220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7369 -5.8178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2534 -6.4862 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4327 -6.4016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0956 -5.6486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5792 -4.9802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3999 -5.0648 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2056 -7.8541 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.5391 -8.3404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8707 -7.8568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1241 -7.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9491 -7.0700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6379 -6.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5441 -10.8154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8288 -10.4043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8271 -9.5793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5408 -9.1654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2561 -9.5764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2577 -10.4014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5457 -11.6404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2610 -12.0514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2626 -12.8764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5490 -13.2903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8337 -12.8793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8321 -12.0543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
7 8 2 0
7 9 1 0
1 7 1 0
4 10 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
17 21 1 0
20 22 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
23 28 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
29 34 2 0
23 29 1 0
18 26 1 0
13 21 1 0
9 11 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 469.62Molecular Weight (Monoisotopic): 469.2049AlogP: 4.84#Rotatable Bonds: 4Polar Surface Area: 81.03Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.49CX LogP: 4.58CX LogD: 4.23Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.33Np Likeness Score: -1.26
References 1. Hagras M, Mohammad H, Mandour MS, Hegazy YA, Ghiaty A, Seleem MN, Mayhoub AS.. (2017) Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA)., 60 (9): [PMID:28436655 ] [10.1021/acs.jmedchem.7b00392 ]